Incyte Corporation News
Avita Medical May Be the Hidden Gem of Biotech Stocks
Avita Medical expects a big second half. Will that set the stage for a multiyear growth runway?
Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?
Valuations for biotech stocks have slumped. This in particular opens up great opportunities for mergers and acquisitions.
Cramer's Mad Money Recap 12/21: Micron Technology, Apple, Amazon, AMD
Jim Cramer says investors may fret about politics and interest rates, but stocks trade on their own merits.
Qualcomm, Fedex Make BofA List of Potential Tax Beneficiaries
Bank of America identifies 13 stocks that may suffer from tax-loss selling through Oct. 31 and then rebound afterward.
Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial
Incyte's Phase 3 study of ruxolitinib missed its primary endpoint of preventing patient deaths from COVID-related acute respiratory distress syndrome.
'Mad Money' Lightning Round: Oracle, Zillow, Pfizer and more
Jim Cramer's bullish on Cognyte Software and Palo Alto Networks, but he says biopharmaceutical companies are under pressure.
Lululemon Stock Slides As Muted Holiday Sales Forecast, Inventory Build Cloud Q3 Earnings Beat
"The external environment remains challenging with several high-volume weeks still in front of us (but) I'm encouraged with the beginning of our holiday season," said CEO Calvin McDonald.
Broadcom Stock Jumps On Q4 Earnings Beat, Solid Near-Term Outlook
"Hyperscale spending continues strong, enterprise consumption continues strong and broadband deployment across North America, Europe and even parts of Asia continues their multiyear trend of growth," said CEO Hock Tan.
Tesla will briefly half production of its Model Y sedan in China over the final week of the year, Reuters reported Friday.
Tesla Prepping Short Model Y Production Halt In Shanghai As China Demand Fades - Report
Activision Stock Slides As FTC Moves to Block $69 Billion Microsoft Takeover
"We seek to stop Microsoft from gaining control over a leading independent game studio and using it to harm competition," the FTC said.